retatrutide clinical trial texas for Weight Loss: TRIUMPH-1 Results, Cost, Insurance Retatrutide Phase 1 Trials |

10.1359/jbmr.071202 45 DingS.-Y.NkobenaA.KraftC

Risks of Fragmented Care Models As remote prescribing of GLP-1 therapies expands, fragmented care has become a growing concern

In recent years, it is believed that GLP-1 and its analogs can affect central nervous system functions such as cognition and neuroprotection (Hunter and Hlscher, 2012

Ongoing monitoring ensures safety, comfort, and optimal progress throughout your journey

For users concerned about maintaining their results long-term, our guides on maintaining weight loss after tirzepatide and weaning off tirzepatide cover the transition process, including how GI symptoms change when you reduce or discontinue the medication

For context, heres how the most recent GLP-1 weight-loss drugs reached UK patients: Wegovy (semaglutide 2.4 mg): MHRA approval September 2021, NICE TA875 issued March 2023